Omics Overview of the SPARC Gene in Mesothelioma
- PMID: 37509139
- PMCID: PMC10377476
- DOI: 10.3390/biom13071103
Omics Overview of the SPARC Gene in Mesothelioma
Abstract
The SPARC gene plays multiple roles in extracellular matrix synthesis and cell shaping, associated with tumor cell migration, invasion, and metastasis. The SPARC gene is also involved in the epithelial-mesenchymal transition (EMT) process, which is a critical phenomenon leading to a more aggressive cancer cell phenotype. SPARC gene overexpression has shown to be associated with poor survival in the mesothelioma (MESO) cohort from the TCGA database, indicating that this gene may be a powerful prognostic factor in MESO. Its overexpression is correlated with the immunosuppressive tumor microenvironment. Here, we summarize the omics advances of the SPARC gene, including the summary of SPARC gene expression associated with prognosis in pancancer and MESO, the immunosuppressive microenvironment, and cancer cell stemness. In addition, SPARC might be targeted by microRNAs. Notably, despite the controversial functions on angiogenesis, SPARC may directly or indirectly contribute to tumor angiogenesis in MESO. In conclusion, SPARC is involved in tumor invasion, metastasis, immunosuppression, cancer cell stemness, and tumor angiogenesis, eventually impacting patient survival. Strategies targeting this gene may provide novel therapeutic approaches to the treatment of MESO.
Keywords: SPARC; epithelial-mesenchymal transition (EMT); mesothelioma (MESO); omics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10377476/bin/biomolecules-13-01103-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10377476/bin/biomolecules-13-01103-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10377476/bin/biomolecules-13-01103-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10377476/bin/biomolecules-13-01103-g004.gif)
Similar articles
-
A panel of emerging EMT genes identified in malignant mesothelioma.Sci Rep. 2022 Jan 19;12(1):1007. doi: 10.1038/s41598-022-04973-x. Sci Rep. 2022. PMID: 35046456 Free PMC article.
-
Prognostic Value of EMT Gene Signature in Malignant Mesothelioma.Int J Mol Sci. 2023 Feb 21;24(5):4264. doi: 10.3390/ijms24054264. Int J Mol Sci. 2023. PMID: 36901697 Free PMC article.
-
Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.Int J Mol Sci. 2017 Jul 18;18(7):1556. doi: 10.3390/ijms18071556. Int J Mol Sci. 2017. PMID: 28718842 Free PMC article.
-
SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.World J Gastroenterol. 2014 Oct 28;20(40):14747-59. doi: 10.3748/wjg.v20.i40.14747. World J Gastroenterol. 2014. PMID: 25356037 Free PMC article. Review.
-
Stromal expression of SPARC in pancreatic adenocarcinoma.Cancer Metastasis Rev. 2013 Dec;32(3-4):585-602. doi: 10.1007/s10555-013-9439-3. Cancer Metastasis Rev. 2013. PMID: 23690170 Review.
References
-
- Rehrauer H., Wu L., Blum W., Pecze L., Henzi T., Serre-Beinier V., Aquino C., Vrugt B., de Perrot M., Schwaller B., et al. How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations. Oncogene. 2018;37:2645–2659. doi: 10.1038/s41388-018-0153-z. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous